COVID-19 News: Chinese Study Finds That Integrin Alpha-5 Beta-1 Facilitates ACE2-Mediated Entry Of SARS-CoV-2

COVID-19 News: The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has sparked an unprecedented global research effort to understand the virus's interactions with host cells. While the angiotensin-converting enzyme 2 (ACE2) receptor has been recognized as the primary gateway for SARS-CoV-2 to enter human cells, alternative receptors and cellular factors have emerged as potential players in this intricate process. Among them, integrins, a family of transmembrane proteins, have been under the spotlight due to their capacity to interact with the virus. In a groundbreaking study conducted by researchers from the First Affiliated Hospital of Xi'an Jiaotong University and the First Affiliated Hospital of Nanchang University in China covered in this COVID-19 News report, the involvement of integrin Alpha-5 Beta-1 (αvβ1) in facilitating ACE2-mediated entry of SARS-CoV-2 was revealed.


A proposed model illustrating the action and mechanism of integrin αvβ1 that facilitates ACE2-mediated viral entry of SARS-CoV-2
-A. ACE2 functions as an independent receptor for SARS-CoV-2 entry into the host cells;
-B. Integrin αvβ1 is unable to serve as an independent receptor for SARS-CoV-2 entry into the host cells;
-C. Integrin αvβ1 may significantly enhance the ACE2-mediated viral entry of SARS-CoV-2.

The SARS-CoV-2 Virus and Its Entry Mechanisms
The spike glycoprotein (S protein) of SARS-CoV-2 plays a critical role in binding to cellular receptors and mediating membrane fusion to gain entry into host cells. Human ACE2 is considered the primary receptor for SARS-CoV-2. However, several alternative receptors have been identified, including neuropilin-1, CD147, and AXL, indicating the virus's adaptability to different host cell types. Moreover, various cellular factors have been proposed to influence the viral entry process, such as non-muscle myosin heavy chain IIA (MYH9), heparan sulfate proteoglycans (HSPGs), sialic acid, and integrins. Integrins, in particular, have drawn attention due to their potential role in the binding and internalization of SARS-CoV-2.
 
Integrins: A Diverse Family of Cell-Adhesion Proteins
Integrins are a family of heterodimeric transmembrane proteins consisting of α and β subunits. They function as Ca2+ or Mg2+-dependent cell adhesion factors, enabling cells to recognize and interact with extracellular matrix molecules and other cell-surface ligands. With 18 subtypes of α subunits and 8 subtypes of β subunits, integrins exhibit remarkable diversity and versatility in cellular interactions. Integrins have also been identified as receptors or co-receptors for various viruses, including human immunodeficiency virus 1 (HIV-1), foot-and-mouth disease virus, human cytomegalovirus, and adeno-associated virus type 2, underlining their significance in viral entry mechanisms.
 
The Controversial Role of Integrins in SARS-CoV-2 Infection
The involvement of integrins in SARS -CoV-2 infection has sparked a significant amount of scientific debate. Researchers have proposed various roles for integrins, ranging from serving as independent cellular receptors competing with ACE2 to acting as facilitators synergizing with ACE2. The presence of the conserved RGD motif (Arg-Gly-Asp, amino acids 403–405) in the receptor binding domain (RBD) of the S protein of SARS-CoV-2 has led to speculation that integrins may play a crucial role in the binding process. However, the exact mechanisms and functions of integrins in SARS-CoV-2 infection remain unclear and subject to controversy, partly due to the diversity and organ-specificity of integrin subtypes.
 
The Study: Exploring Integrin Alpha-5 Beta-1 (αvβ1) in SARS-CoV-2 Entry
In their pioneering research, the Chinese scientists aimed to shed light on the involvement of integrins in facilitating ACE2-mediated entry of SARS-CoV-2. They conducted a series of experiments to assess the susceptibility of various human cell lines to SARS-CoV-2 infection and to examine the expression levels of integrins in these cells using quantitative polymerase chain reaction (qPCR), western blot analysis, and flow cytometry. Their investigation revealed that integrin αvβ1 was highly enriched in cell lines susceptible to SARS-CoV-2 infection. This finding raised questions about the specific role of integrin αvβ1 in the viral entry process.
 
Key Findings of the Study
-High Expression of Integrin αvβ1 in SARS-CoV-2 Susceptible Cell Lines:
The researchers found that integrin αvβ1 was significantly enriched in the cell lines that were susceptible to SARS-CoV-2 infection. This observation indicated a potential connection between integrin αvβ1 expression and viral susceptibility, suggesting that this integrin might play a crucial role in the infection process.
 
-Interaction between the RGD Motif and Integrin αvβ1:
To investigate the interaction between the RGD motif on the S protein of SARS-CoV-2 and integrin αvβ1, the researchers generated a mutant virus with the RGD (403–405) motif mutated to AAA. This mutation not only impaired viral entry but also affected the cleavage of the S protein. The results raised questions about potential cleavage methods near the RGD motif, which should be a subject of future investigations.
 
-Anti-αvβ1 Integrin Antibodies Inhibited Viral Entry:
The study also explored the inhibitory effects of anti-αvβ1 integrin antibodies on SARS-CoV-2 entry. The results showed that these antibodies could significantly reduce viral infectivity, further implicating integrin αvβ1 in the viral entry process.
 
-Integrin αvβ1 Facilitates ACE2-Mediated Viral Entry:
Intriguingly, the study demonstrated that integrin αvβ1 does not act as an independent receptor for the cellular entry of SARS-CoV-2. Instead, it functions as a facilitator, enhancing the ACE2-mediated viral entry process. This finding provided valuable insights into the complex interplay between SARS-CoV-2 and host cell receptors.
 
Implications and Future Directions
This Chinese study offers a groundbreaking perspective on the role of integrin αvβ1 in facilitating ACE2-mediated entry of SARS-CoV-2. The findings have the potential to enhance our understanding of the pathogenesis of COVID-19 and provide a novel therapeutic target for combating the virus. Understanding the mechanisms by which integrins interact with SARS-CoV-2 can aid in the development of targeted treatments and preventive measures.
 
The study also points to the significance of investigating the impact of emerging SARS-CoV-2 variants, such as the Omicron variant, on the viral entry process. The observation of increased ACE2-mediated viral entry with the Omicron variant aligns with previous research indicating the importance of integrin signaling in the virus's infectivity. Future studies may further explore the consequences of RGD motif mutations, such as RGN, in Omicron variants and their effects on viral entry.
 
It is worth noting that this study, like any scientific research, has limitations. The use of established cell lines infected with pseudotyped viruses may not fully represent the real conditions of viral entry events. Further validation studies using primary human cells or patient-derived organoids infected with wild-type or mutant SARS-CoV-2 are warranted to confirm and expand upon these findings.
 
In conclusion, the discovery of integrin αvβ1's role as a facilitator in ACE2-mediated SARS-CoV-2 entry underscores the complexity of the virus's interactions with host cells. This research opens new avenues for investigation and offers hope for the development of targeted therapies to combat the COVID-19 pandemic. As the world continues to grapple with the challenges posed by SARS-CoV-2, insights like those revealed in this study are invaluable in the ongoing battle against the virus.
 
The study findings were published in the peer reviewed journal: Virus Research.
https://www.sciencedirect.com/science/article/pii/S0168170223002137
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.